iLearningEngines logo.jpg
iLearningEngines and GenLab Venture Studio Announce Strategic Alliance to fast-track Enterprise AI Applications Using Generative AI within Global Enterprises
September 18, 2024 17:00 ET | iLearningEngines Holdings, Inc.
BETHESDA, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (Nasdaq: AILE) (“iLearningEngines,” “ILE,” or “the Company”), a leader in AI-powered learning and work automation for...
fanhua_logo.jpg
Fanhua Reports First Half 2024 Unaudited Financial Results
September 18, 2024 17:00 ET | Fanhua Inc.
GUANGZHOU, China, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced its unaudited...
Aligos.png
Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024
September 18, 2024 17:00 ET | Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient...
Cytek Logo - Color.jpg
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET | Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
ultragenyx-CMYK.png
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024 17:00 ET | Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance
September 18, 2024 16:30 ET | Mountain Crest Acquisition Corp. V
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) --  Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the...
W_Logo__RGB.png
Woodward Announces Declaration of Dividend
September 18, 2024 16:30 ET | Woodward, Inc.
Woodward Announces Declaration of Dividend
CLBT Logo.png
Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants
September 18, 2024 16:15 ET | Cellebrite DI Ltd
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital...
ECD Automotive Logo_final.png
ECD Auto Design Announces CFO Transition and Board Restructure
September 18, 2024 16:15 ET | E.C.D. Automotive Design
KISSIMMEE, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), an industry leader in delivering restored, modified and...
Nanobiotix logo.jpg
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
September 18, 2024 16:15 ET | Nanobiotix S.A.
RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune...